Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]

Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] was reported 9728 times

Drugs of the Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 GLOBOTRIAOSYLCERAMIDE 5 1.0000
1 GLOBOTRIAOSYLCERAMIDE INCREASED 103 0.9810
2 GLOBOTRIAOSYLSPHINGOSINE INCREASED 189 0.9643
3 FABRY'S DISEASE 23 0.6571
4 LYSOSOMAL STORAGE DISORDER 8 0.4211
5 VERTEBROBASILAR DOLICHOECTASIA 4 0.4000
6 ANGIOKERATOMA 31 0.3647
7 ANTIBODY TEST 19 0.2603
8 NEUTRALISING ANTIBODIES POSITIVE 66 0.1583
9 NEUTRALISING ANTIBODIES NEGATIVE 6 0.1538
10 DRUG SPECIFIC ANTIBODY ABSENT 18 0.0882
11 ANTIBODY TEST NEGATIVE 17 0.0863
12 COMPLEMENT FACTOR C3 INCREASED 9 0.0857
13 TONIC POSTURING 4 0.0656
14 DELAYED SLEEP PHASE 3 0.0366
15 DRUG SPECIFIC ANTIBODY PRESENT 220 0.0338
16 ANHIDROSIS 12 0.0294
17 RENAL TRANSPLANT 87 0.0241
18 CORNEA VERTICILLATA 7 0.0230
19 IN VITRO FERTILISATION 4 0.0221
20 CENTRAL LINE INFECTION 8 0.0216
21 CARDIAC HYPERTROPHY 24 0.0215
22 ANTIBODY TEST POSITIVE 35 0.0211
23 HYPOHIDROSIS 10 0.0199
24 QUARANTINE 4 0.0195
25 AORTIC VALVE THICKENING 3 0.0186
26 BLOOD IMMUNOGLOBULIN G INCREASED 21 0.0173
27 PERITONEAL DIALYSIS 14 0.0169
28 BRAIN STEM ISCHAEMIA 3 0.0168
29 URTICARIA GENERALISED 10 0.0154
30 INFUSION SITE THROMBOSIS 4 0.0149
31 GASTROINTESTINAL ISCHAEMIA 4 0.0144
32 HYPERTROPHIC CARDIOMYOPATHY 20 0.0129
33 CATHETER SITE BRUISE 4 0.0121
34 CEREBRAL CALCIFICATION 3 0.0112
35 GLOMERULONEPHRITIS MEMBRANOUS 13 0.0111
36 RENAL FAILURE CHRONIC 85 0.0110
37 INFUSION SITE EXTRAVASATION 68 0.0109
38 MYOCARDIAL NECROSIS MARKER INCREASED 18 0.0107
39 CENTRAL VENOUS CATHETER REMOVAL 5 0.0107
40 ALBUMINURIA 5 0.0093
41 PATERNAL EXPOSURE DURING PREGNANCY 8 0.0093
42 VENTRICULAR HYPERTROPHY 23 0.0092
43 POOR VENOUS ACCESS 91 0.0088
44 CATHETER REMOVAL 3 0.0084
45 MYOCARDIAL FIBROSIS 7 0.0083
46 AURICULAR SWELLING 5 0.0083
47 BRAIN STEM STROKE 4 0.0081
48 INFUSION SITE RASH 11 0.0080
49 MICROALBUMINURIA 6 0.0079
50 ALBUMIN URINE PRESENT 3 0.0079
51 INFUSION SITE DISCOMFORT 8 0.0077
52 CEREBELLAR STROKE 3 0.0077
53 EXPOSURE TO SARS-COV-2 13 0.0076
54 ASYMPTOMATIC COVID-19 3 0.0076
55 CATHETER PLACEMENT 14 0.0075
56 LEFT VENTRICULAR HYPERTROPHY 32 0.0075
57 INFUSION SITE URTICARIA 5 0.0075
58 INCORRECT DRUG ADMINISTRATION RATE 30 0.0070
59 BRAIN STEM INFARCTION 7 0.0068
60 INFUSION SITE REACTION 20 0.0067
61 END STAGE RENAL DISEASE 122 0.0067
62 CARDIAC PACEMAKER REPLACEMENT 3 0.0065
63 AORTIC DILATATION 7 0.0063
64 BLOOD CREATINE ABNORMAL 3 0.0062
65 CARDIAC STRESS TEST ABNORMAL 5 0.0060
66 VEIN RUPTURE 10 0.0060
67 CATHETER RELATED INFECTION 6 0.0059
68 VASOCONSTRICTION 5 0.0057
69 CARDIAC PACEMAKER INSERTION 34 0.0057
70 SYSTOLIC DYSFUNCTION 6 0.0057
71 CARDIAC OUTPUT DECREASED 5 0.0057
72 HEART TRANSPLANT 5 0.0055
73 TEMPERATURE INTOLERANCE 57 0.0055
74 SKIN TEST POSITIVE 5 0.0054
75 CATHETER SITE SWELLING 5 0.0053
76 BUNDLE BRANCH BLOCK 5 0.0053
77 CORNEAL OPACITY 7 0.0051
78 HAEMODIALYSIS 42 0.0050
79 PERFORATION 4 0.0050
80 BLOOD IMMUNOGLOBULIN E INCREASED 12 0.0050
81 COMPLICATIONS OF TRANSPLANTED KIDNEY 11 0.0048
82 INFUSION RELATED REACTION 317 0.0048
83 EXPOSURE VIA BREAST MILK 19 0.0048
84 CATHETER SITE PAIN 12 0.0046
85 SUSPECTED COVID-19 15 0.0045
86 IMPLANTABLE DEFIBRILLATOR INSERTION 6 0.0045
87 DRUG SPECIFIC ANTIBODY 6 0.0044
88 LIVEDO RETICULARIS 9 0.0043
89 TRANSIENT ISCHAEMIC ATTACK 145 0.0043
90 CHILLS 494 0.0042
91 HEART VALVE INCOMPETENCE 12 0.0042
92 NOROVIRUS INFECTION 6 0.0042
93 VESTIBULAR DISORDER 5 0.0041
94 TRANSPLANT FAILURE 10 0.0041
95 CARDIAC INFECTION 3 0.0040
96 CENTRAL VENOUS CATHETERISATION 12 0.0040
97 SUDDEN HEARING LOSS 8 0.0040
98 CARDIAC ABLATION 7 0.0039
99 INFUSION SITE PRURITUS 12 0.0038
100 SARS-COV-2 TEST POSITIVE 50 0.0038
101 KIDNEY TRANSPLANT REJECTION 18 0.0037
102 AORTIC VALVE DISEASE 6 0.0037
103 MITRAL VALVE INCOMPETENCE 42 0.0037
104 PROTEINURIA 70 0.0037
105 CARDIAC VALVE DISEASE 21 0.0037
106 INFUSION SITE SWELLING 23 0.0037
107 MENINGITIS VIRAL 5 0.0036
108 CONGENITAL CYSTIC KIDNEY DISEASE 3 0.0035
109 DEAFNESS TRANSITORY 3 0.0035
110 CRANIOFACIAL FRACTURE 3 0.0035
111 CARBON DIOXIDE DECREASED 4 0.0035
112 PROTEIN URINE PRESENT 17 0.0034
113 VEIN DISORDER 17 0.0034
114 BODY TEMPERATURE INCREASED 69 0.0034
115 BLOOD CULTURE POSITIVE 10 0.0033
116 TROPONIN INCREASED 25 0.0033
117 INTERVERTEBRAL DISC OPERATION 4 0.0032
118 BLOOD UREA DECREASED 4 0.0032
119 TUNNEL VISION 6 0.0032
120 PRODUCT PREPARATION ISSUE 21 0.0032
121 BRAIN STEM HAEMORRHAGE 3 0.0032
122 DIALYSIS 45 0.0032
123 DENGUE FEVER 7 0.0030
124 BRADYARRHYTHMIA 5 0.0030
125 CARDIAC DISCOMFORT 6 0.0030
126 SUDDEN CARDIAC DEATH 10 0.0029
127 FEELING COLD 81 0.0029
128 DEAFNESS UNILATERAL 16 0.0029
129 BLOOD CREATININE DECREASED 9 0.0029
130 ECHOCARDIOGRAM ABNORMAL 4 0.0029
131 DEVICE RELATED INFECTION 44 0.0029
132 CARDIOMYOPATHY 42 0.0028
133 DISEASE COMPLICATION 13 0.0028
134 APPENDIX DISORDER 4 0.0028
135 AORTIC VALVE INCOMPETENCE 12 0.0028
136 TACHYARRHYTHMIA 7 0.0028
137 AORTIC VALVE STENOSIS 5 0.0028
138 NEURALGIA 68 0.0028
139 INFUSION SITE BRUISING 6 0.0028
140 AZOTAEMIA 11 0.0028
141 LYMPHOEDEMA 19 0.0027
142 COCCYDYNIA 4 0.0027
143 THROAT TIGHTNESS 73 0.0027
144 WHITE BLOOD CELLS URINE POSITIVE 5 0.0027
145 RENAL COLIC 6 0.0027
146 BUNDLE BRANCH BLOCK RIGHT 12 0.0026
147 BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0026
148 CARDIAC FAILURE CHRONIC 11 0.0026
149 UTERINE DISORDER 6 0.0026
150 VENTRICULAR TACHYCARDIA 42 0.0025
151 MULTI-ORGAN DISORDER 5 0.0025
152 INTERCEPTED PRODUCT STORAGE ERROR 9 0.0025
153 ATRIAL FLUTTER 20 0.0025
154 MATERNAL EXPOSURE DURING BREAST FEEDING 10 0.0025
155 DEAFNESS NEUROSENSORY 8 0.0024
156 LEG AMPUTATION 10 0.0024
157 INFUSION SITE PAIN 31 0.0024
158 AORTIC VALVE REPLACEMENT 3 0.0024
159 WEIGHT FLUCTUATION 25 0.0024
160 DILATATION VENTRICULAR 5 0.0024
161 VASCULAR OCCLUSION 5 0.0024
162 CEREBELLAR INFARCTION 4 0.0024
163 GASTRIC INFECTION 9 0.0024
164 ENDOCARDITIS 12 0.0023
165 BURNING SENSATION 164 0.0023
166 STREPTOCOCCAL INFECTION 13 0.0023
167 CEREBRAL ISCHAEMIA 12 0.0023
168 ILLNESS 240 0.0023
169 CEREBROVASCULAR DISORDER 7 0.0023
170 PUPIL FIXED 4 0.0023
171 DIASTOLIC DYSFUNCTION 7 0.0023
172 PHARYNGOLARYNGEAL PAIN 12 0.0023
173 MUSCLE CRAMP 4 0.0023
174 BLOOD POTASSIUM ABNORMAL 6 0.0022
175 HYPERLACTACIDAEMIA 6 0.0022
176 PHARYNGITIS STREPTOCOCCAL 24 0.0022
177 ATRIAL FIBRILLATION 215 0.0022
178 CORNEAL ABRASION 3 0.0022
179 ANAPHYLACTOID REACTION 9 0.0022
180 CARDIAC FLUTTER 14 0.0022
181 CARDIAC DYSFUNCTION 8 0.0021
182 CARDIOVERSION 3 0.0021
183 INTENTIONAL DOSE OMISSION 61 0.0021
184 HYPOPROTEINAEMIA 4 0.0021
185 HEART RATE DECREASED 74 0.0021
186 GASTROENTERITIS VIRAL 38 0.0021
187 CEREBRAL INFARCTION 51 0.0021
188 STRIDOR 6 0.0020
189 DEAFNESS 53 0.0020
190 BLOOD CREATININE ABNORMAL 7 0.0020
191 ATYPICAL PNEUMONIA 6 0.0020
192 CORONARY ARTERY STENOSIS 10 0.0020
193 APPENDICITIS PERFORATED 5 0.0020
194 LARYNGEAL OEDEMA 12 0.0019
195 DIVERTICULAR PERFORATION 4 0.0019
196 ARRHYTHMIA 92 0.0019
197 ATRIOVENTRICULAR BLOCK COMPLETE 13 0.0019
198 CARDIAC DISORDER 179 0.0019
199 SKIN ABRASION 9 0.0019
200 FOOD POISONING 10 0.0019
201 TENSION HEADACHE 8 0.0019
202 LOWER RESPIRATORY TRACT INFECTION 84 0.0018
203 LIGAMENT SPRAIN 18 0.0018
204 COLONIC POLYP 3 0.0018
205 ELECTROCARDIOGRAM T WAVE INVERSION 4 0.0018
206 GASTROINTESTINAL ULCER 4 0.0018
207 TRICUSPID VALVE INCOMPETENCE 14 0.0018
208 INTRACRANIAL ANEURYSM 7 0.0017
209 EXERCISE TOLERANCE DECREASED 10 0.0017
210 BLOOD CHLORIDE INCREASED 3 0.0017
211 PERIORBITAL OEDEMA 9 0.0017
212 UPPER RESPIRATORY TRACT CONGESTION 5 0.0017
213 DECUBITUS ULCER 14 0.0017
214 RESPIRATORY TRACT INFECTION VIRAL 4 0.0017
215 VENTRICULAR FIBRILLATION 19 0.0017
216 BLOOD PRESSURE ABNORMAL 34 0.0017
217 BRAIN HERNIATION 5 0.0017
218 WHEEZING 99 0.0017
219 HEARING IMPAIRED 10 0.0017
220 WEIGHT ABNORMAL 4 0.0017
221 PRODUCT ADMINISTRATION INTERRUPTED 13 0.0017
222 BUNDLE BRANCH BLOCK LEFT 7 0.0016
223 VENTRICULAR ARRHYTHMIA 6 0.0016
224 CONDUCTION DISORDER 3 0.0016
225 VENTRICULAR EXTRASYSTOLES 17 0.0016
226 GLOMERULONEPHRITIS 4 0.0016
227 BODY TEMPERATURE ABNORMAL 3 0.0016
228 CARDIOMEGALY 20 0.0016
229 CHEST DISCOMFORT 166 0.0016
230 BLOOD PRESSURE DECREASED 107 0.0016
231 APPENDICITIS 15 0.0016
232 CATHETER SITE HAEMORRHAGE 4 0.0016
233 HEMIPARESIS 27 0.0016
234 ERYSIPELAS 8 0.0016
235 BLOOD CREATINE INCREASED 7 0.0016
236 PALLOR 43 0.0016
237 TOE AMPUTATION 8 0.0016
238 PYREXIA 543 0.0016
239 HEMIPLEGIA 13 0.0016
240 STUPOR 5 0.0016
241 CACHEXIA 8 0.0016
242 HAND FRACTURE 11 0.0016
243 ATRIOVENTRICULAR BLOCK 12 0.0016
244 OSTEOMYELITIS 28 0.0015
245 INFUSION SITE ERYTHEMA 13 0.0015
246 CARDIOPULMONARY FAILURE 6 0.0015
247 RENAL IMPAIRMENT 129 0.0015
248 CEREBROVASCULAR ACCIDENT 257 0.0015
249 SUDDEN DEATH 16 0.0015
250 EXPOSURE DURING BREAST FEEDING 5 0.0015
251 RENAL FUNCTION TEST ABNORMAL 7 0.0015
252 RENAL DISORDER 70 0.0015
253 ANGIONEUROTIC OEDEMA 4 0.0015
254 LYME DISEASE 5 0.0015
255 LOCALISED INFECTION 36 0.0015
256 CORONARY ARTERY THROMBOSIS 3 0.0015
257 BLOOD SODIUM INCREASED 4 0.0015
258 EXPOSURE DURING PREGNANCY 91 0.0015
259 EXTRAVASATION 6 0.0015
260 LEFT VENTRICULAR FAILURE 5 0.0015
261 CELLULITIS 73 0.0014
262 BODY TEMPERATURE FLUCTUATION 3 0.0014
263 HEART RATE ABNORMAL 8 0.0014
264 NECK MASS 4 0.0014
265 FACIAL PARESIS 5 0.0014
266 CHEST PAIN 261 0.0014
267 HAEMORRHAGIC STROKE 11 0.0014
268 FACIAL PARALYSIS 12 0.0014
269 CARDIAC FAILURE 113 0.0014
270 RESPIRATORY SYMPTOM 4 0.0014
271 ANEURYSM 7 0.0014
272 THROAT IRRITATION 63 0.0014
273 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
274 CATHETER SITE ERYTHEMA 3 0.0014
275 APPENDICECTOMY 5 0.0014
276 NEUROLOGICAL SYMPTOM 8 0.0014
277 BRADYCARDIA 74 0.0014
278 NEPHROPATHY 13 0.0014
279 CORONARY ARTERY OCCLUSION 19 0.0014
280 STAPHYLOCOCCAL BACTERAEMIA 6 0.0014
281 BLOOD UREA INCREASED 23 0.0014
282 CORNEAL DISORDER 3 0.0014
283 ACCIDENT AT WORK 3 0.0014
284 CATHETERISATION CARDIAC 6 0.0014
285 CARDIAC FAILURE ACUTE 9 0.0013
286 TINNITUS 62 0.0013
287 URINE ANALYSIS ABNORMAL 4 0.0013
288 CRANIOCEREBRAL INJURY 4 0.0013
289 PARANASAL SINUS DISCOMFORT 5 0.0013
290 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
291 ISCHAEMIC CARDIOMYOPATHY 4 0.0013
292 GLOMERULAR FILTRATION RATE DECREASED 16 0.0013
293 WEIGHT INCREASED 291 0.0013
294 BRAIN DEATH 4 0.0013
295 ARTHRITIS INFECTIVE 6 0.0013
296 FORMICATION 9 0.0013
297 ISCHAEMIC STROKE 23 0.0013
298 HYPOTHERMIA 13 0.0013
299 EPIGASTRIC DISCOMFORT 5 0.0013
300 WEIGHT DECREASED 356 0.0013
301 PARAESTHESIA 199 0.0013
302 PRE-ECLAMPSIA 6 0.0013
303 ACUTE PULMONARY OEDEMA 7 0.0012
304 INFLUENZA 139 0.0012
305 STENT PLACEMENT 10 0.0012
306 FEELING HOT 76 0.0012
307 FLUSHING 126 0.0012
308 SPINAL FUSION SURGERY 5 0.0012
309 ANGINA UNSTABLE 8 0.0012
310 ANGINA PECTORIS 35 0.0012
311 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 4 0.0012
312 MENINGITIS 8 0.0012
313 GASTROINTESTINAL DISORDER 107 0.0012
314 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
315 HYPOAESTHESIA ORAL 18 0.0012
316 UPPER RESPIRATORY TRACT INFECTION 55 0.0012
317 SENSATION OF FOREIGN BODY 10 0.0012
318 STAPHYLOCOCCAL INFECTION 39 0.0012
319 TOOTH ABSCESS 12 0.0012
320 FLANK PAIN 11 0.0012
321 VIRAL INFECTION 39 0.0012
322 SHOULDER OPERATION 5 0.0012
323 VIITH NERVE PARALYSIS 4 0.0012
324 HYSTERECTOMY 10 0.0012
325 HEART RATE IRREGULAR 26 0.0011
326 MALAISE 504 0.0011
327 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
328 AORTIC STENOSIS 4 0.0011
329 EMBOLIC STROKE 4 0.0011
330 DIZZINESS POSTURAL 11 0.0011
331 RESPIRATORY TRACT CONGESTION 18 0.0011
332 VERTIGO 69 0.0011
333 PAIN IN EXTREMITY 333 0.0011
334 WHEELCHAIR USER 5 0.0011
335 HEART RATE INCREASED 111 0.0011
336 EYELID OEDEMA 13 0.0011
337 PARAESTHESIA ORAL 16 0.0011
338 BLOOD PHOSPHORUS INCREASED 3 0.0011
339 PERIPHERAL COLDNESS 15 0.0011
340 ACUTE CORONARY SYNDROME 9 0.0011
341 WOUND HAEMORRHAGE 4 0.0011
342 CEREBRAL DISORDER 8 0.0011
343 CHOLECYSTITIS INFECTIVE 3 0.0011
344 TACHYCARDIA 96 0.0011
345 URTICARIA 181 0.0011
346 ARTHROPOD BITE 8 0.0011
347 ANGIOPATHY 6 0.0011
348 FACE OEDEMA 18 0.0011
349 PERITONITIS 22 0.0011
350 TOOTH INFECTION 14 0.0011
351 WALKING AID USER 7 0.0011
352 SNORING 4 0.0011
353 CATHETER SITE INFECTION 4 0.0011
354 TENDERNESS 11 0.0011
355 COVID-19 185 0.0011
356 EAR INFECTION 28 0.0011
357 CARDIAC OPERATION 9 0.0010
358 COMMUNICATION DISORDER 4 0.0010
359 LIMB OPERATION 5 0.0010
360 POST PROCEDURAL COMPLICATION 20 0.0010
361 CARDIAC MURMUR 9 0.0010
362 RENAL FAILURE 138 0.0010
363 SINUS CONGESTION 14 0.0010
364 RALES 6 0.0010
365 SKIN WARM 6 0.0010
366 TREMOR 171 0.0010
367 PRESYNCOPE 25 0.0010
368 HYPOVOLAEMIA 6 0.0010
369 INFARCTION 7 0.0010
370 PRODUCT PREPARATION ERROR 21 0.0010
371 BRAIN FOG 16 0.0010
372 KIDNEY INFECTION 20 0.0010
373 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
374 BLOOD PRESSURE INCREASED 155 0.0010
375 HYPERVOLAEMIA 5 0.0010
376 ANOREXIA 13 0.0010
377 INFLAMMATORY MARKER INCREASED 5 0.0010
378 WOUND INFECTION 11 0.0010
379 GASTROINTESTINAL INFECTION 9 0.0010
380 GOUT 18 0.0010
381 SENSORY LOSS 8 0.0010
382 RHINITIS 8 0.0010
383 SYNCOPE 99 0.0010
384 HERNIA 19 0.0010
385 CARDIAC ARREST 81 0.0010
386 ROAD TRAFFIC ACCIDENT 41 0.0010
387 BLOOD CALCIUM DECREASED 11 0.0010
388 PHLEBITIS 5 0.0010
389 COUGH 273 0.0010
390 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
391 EJECTION FRACTION DECREASED 15 0.0010
392 MICTURITION URGENCY 11 0.0010
393 LIP SWELLING 32 0.0010
394 NASOPHARYNGITIS 177 0.0010
395 LIMB INJURY 26 0.0010
396 CYANOSIS 15 0.0010
397 BLINDNESS TRANSIENT 7 0.0009
398 CONDITION AGGRAVATED 287 0.0009
399 SINUSITIS 96 0.0009
400 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
401 ANURIA 8 0.0009
402 MUSCLE STRAIN 8 0.0009
403 SEASONAL ALLERGY 13 0.0009
404 PROCEDURAL COMPLICATION 7 0.0009
405 INTESTINAL ISCHAEMIA 5 0.0009
406 ANAPHYLACTIC REACTION 50 0.0009
407 CONCUSSION 7 0.0009
408 DYSARTHRIA 34 0.0009
409 NASAL CONGESTION 53 0.0009
410 RESPIRATORY RATE INCREASED 8 0.0009
411 OVARIAN CYST 9 0.0009
412 PALPITATIONS 105 0.0009
413 OEDEMA PERIPHERAL 109 0.0009
414 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
415 INTESTINAL PERFORATION 10 0.0009
416 DISEASE PROGRESSION 105 0.0009
417 CLOSTRIDIAL INFECTION 3 0.0009
418 OROPHARYNGEAL DISCOMFORT 8 0.0009
419 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
420 PAIN 540 0.0009
421 MYOCARDIAL ISCHAEMIA 10 0.0009
422 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 158 0.0009
423 EYE MOVEMENT DISORDER 6 0.0009
424 EAR PAIN 17 0.0009
425 EAR DISORDER 4 0.0009
426 PRODUCT DOSE OMISSION 57 0.0009
427 OXYGEN SATURATION DECREASED 49 0.0009
428 BLOOD URIC ACID INCREASED 5 0.0009
429 BRONCHITIS 64 0.0009
430 EXTRASYSTOLES 6 0.0009
431 CARDIAC FAILURE CONGESTIVE 69 0.0009
432 CAROTID ARTERY STENOSIS 3 0.0009
433 MULTIPLE MYELOMA 4 0.0009
434 CARPAL TUNNEL SYNDROME 12 0.0009
435 UPPER LIMB FRACTURE 17 0.0009
436 TIBIA FRACTURE 4 0.0009
437 DEVICE OCCLUSION 12 0.0009
438 RENAL PAIN 9 0.0008
439 SNEEZING 19 0.0008
440 BLOOD CREATININE INCREASED 55 0.0008
441 VOMITING 394 0.0008
442 CARDIO-RESPIRATORY ARREST 35 0.0008
443 APHAGIA 4 0.0008
444 GANGRENE 5 0.0008
445 ENTEROCOCCAL INFECTION 4 0.0008
446 LOSS OF CONSCIOUSNESS 106 0.0008
447 HOSPITALISATION 127 0.0008
448 CAROTID ARTERY OCCLUSION 3 0.0008
449 DYSURIA 30 0.0008
450 BODY TEMPERATURE DECREASED 8 0.0008
451 FOOT OPERATION 4 0.0008
452 SKIN INFECTION 9 0.0008
453 RESPIRATORY DISORDER 24 0.0008
454 URINE OUTPUT DECREASED 7 0.0008
455 GROIN PAIN 7 0.0008
456 BLEPHAROSPASM 5 0.0008
457 FOOT FRACTURE 15 0.0008
458 KLEBSIELLA INFECTION 4 0.0008
459 AORTIC ANEURYSM 6 0.0008
460 HYPERTHERMIA 6 0.0008
461 CLAVICLE FRACTURE 3 0.0008
462 SPEECH DISORDER 41 0.0008
463 CEREBRAL HAEMORRHAGE 28 0.0008
464 ANAL INCONTINENCE 7 0.0008
465 STOMACH DISCOMFORT 4 0.0008
466 INCOHERENT 5 0.0008
467 DYSPNOEA 437 0.0008
468 PELVIC FRACTURE 6 0.0008
469 TREATMENT NONCOMPLIANCE 42 0.0008
470 MALABSORPTION 4 0.0008
471 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
472 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
473 BEDRIDDEN 10 0.0008
474 SENSITIVITY TO WEATHER CHANGE 4 0.0008
475 HYPOTENSION 152 0.0008
476 ILL-DEFINED DISORDER 46 0.0008
477 PNEUMOTHORAX 12 0.0008
478 UNEVALUABLE EVENT 57 0.0008
479 SCIATICA 12 0.0008
480 MULTI-ORGAN FAILURE 13 0.0008
481 JOINT INJURY 16 0.0007
482 OVERWEIGHT 4 0.0007
483 HYPOACUSIS 32 0.0007
484 HYPOAESTHESIA 111 0.0007
485 POSTOPERATIVE WOUND INFECTION 5 0.0007
486 COLD SWEAT 13 0.0007
487 PRODUCTIVE COUGH 35 0.0007
488 NONSPECIFIC REACTION 4 0.0007
489 APHASIA 22 0.0007
490 GALLBLADDER DISORDER 13 0.0007
491 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
492 RHINORRHOEA 47 0.0007
493 ILEUS 9 0.0007
494 CONGESTIVE CARDIOMYOPATHY 3 0.0007
495 HYPERTENSIVE CRISIS 8 0.0007
496 DYSPNOEA EXERTIONAL 27 0.0007
497 MALNUTRITION 8 0.0007
498 NEUROPATHY PERIPHERAL 68 0.0007
499 FISTULA 8 0.0007
500 MYOCARDIAL INFARCTION 124 0.0007
501 ABDOMINAL PAIN 165 0.0007
502 URINARY TRACT INFECTION 119 0.0007
503 VISUAL FIELD DEFECT 5 0.0007
504 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
505 RESPIRATORY TRACT INFECTION 18 0.0007
506 FLUID OVERLOAD 10 0.0007
507 DIVERTICULITIS 19 0.0007
508 GASTROENTERITIS 10 0.0007
509 HIP FRACTURE 22 0.0007
510 UTERINE LEIOMYOMA 5 0.0007
511 THROMBOSIS 55 0.0007
512 PRODUCT DOSE OMISSION ISSUE 201 0.0007
513 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
514 ABDOMINAL ABSCESS 3 0.0007
515 LOWER LIMB FRACTURE 13 0.0007
516 BACK DISORDER 11 0.0007
517 MEDICAL DEVICE COMPLICATION 5 0.0007
518 NEPHROLITHIASIS 31 0.0007
519 BLOOD IRON DECREASED 8 0.0007
520 BACTERAEMIA 8 0.0007
521 SINUS HEADACHE 4 0.0007
522 SEPSIS 75 0.0007
523 FLUID RETENTION 34 0.0007
524 SYMPTOM RECURRENCE 4 0.0007
525 WRIST FRACTURE 8 0.0007
526 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
527 EATING DISORDER 14 0.0007
528 HYPERTENSION 139 0.0007
529 DISCOMFORT 40 0.0007
530 HIP ARTHROPLASTY 10 0.0007
531 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
532 NERVE COMPRESSION 6 0.0006
533 MIGRAINE 62 0.0006
534 GENERALISED OEDEMA 8 0.0006
535 MUSCULOSKELETAL CHEST PAIN 10 0.0006
536 CIRCULATORY COLLAPSE 11 0.0006
537 SWOLLEN TONGUE 20 0.0006
538 HYPERHIDROSIS 82 0.0006
539 FALL 211 0.0006
540 SPINAL DISORDER 6 0.0006
541 BRAIN OEDEMA 8 0.0006
542 NAUSEA 501 0.0006
543 DENTAL CARIES 7 0.0006
544 RIB FRACTURE 13 0.0006
545 INFLUENZA LIKE ILLNESS 52 0.0006
546 BRONCHOSPASM 9 0.0006
547 BLOOD ALBUMIN DECREASED 5 0.0006
548 RENAL CYST 5 0.0006
549 RESTLESSNESS 23 0.0006
550 BLOOD PRESSURE FLUCTUATION 15 0.0006
551 GENERAL PHYSICAL HEALTH DETERIORATION 72 0.0006
552 HEADACHE 390 0.0006
553 HEAD DISCOMFORT 11 0.0006
554 EYE INFECTION 7 0.0006
555 BLOOD POTASSIUM INCREASED 10 0.0006
556 SURGERY 36 0.0006
557 ASPHYXIA 5 0.0006
558 CONVULSION 35 0.0006
559 ABDOMINAL PAIN UPPER 126 0.0006
560 POLYP 4 0.0006
561 ACUTE MYOCARDIAL INFARCTION 18 0.0006
562 BREATH SOUNDS ABNORMAL 3 0.0006
563 OROPHARYNGEAL PAIN 56 0.0006
564 DIZZINESS 300 0.0006
565 FATIGUE 468 0.0006
566 HEAD INJURY 19 0.0006
567 SKIN MASS 4 0.0006
568 SWELLING FACE 39 0.0006
569 PERIPHERAL SWELLING 92 0.0006
570 CORONARY ARTERIAL STENT INSERTION 3 0.0006
571 ERYTHEMA 121 0.0006
572 IMPAIRED GASTRIC EMPTYING 8 0.0006
573 ACCIDENT 7 0.0006
574 VITAMIN D DECREASED 5 0.0006
575 TOOTH DISORDER 13 0.0006
576 EAR DISCOMFORT 6 0.0006
577 ECCHYMOSIS 4 0.0006
578 MATERNAL EXPOSURE DURING PREGNANCY 52 0.0006
579 ANKLE FRACTURE 9 0.0006
580 PULMONARY OEDEMA 26 0.0006
581 DISORIENTATION 23 0.0006
582 SKIN ULCER 15 0.0006
583 SEIZURE 67 0.0006
584 PETECHIAE 6 0.0006
585 OEDEMA 31 0.0006
586 SPINAL OPERATION 7 0.0006
587 TENDON RUPTURE 7 0.0006
588 CYSTITIS 18 0.0006
589 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
590 CYST 7 0.0006
591 PERICARDIAL EFFUSION 13 0.0006
592 CORONARY ARTERY DISEASE 17 0.0006
593 SENSORY DISTURBANCE 9 0.0006
594 FEELING ABNORMAL 134 0.0006
595 SINUS DISORDER 11 0.0006
596 AMNESIA 36 0.0006
597 SKIN LACERATION 6 0.0006
598 BACK INJURY 6 0.0006
599 PRURITUS 212 0.0006
600 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
601 LIMB DISCOMFORT 17 0.0005
602 ABDOMINAL DISCOMFORT 92 0.0005
603 GASTROINTESTINAL PAIN 6 0.0005
604 ROTATOR CUFF SYNDROME 7 0.0005
605 SWELLING 51 0.0005
606 UROSEPSIS 5 0.0005
607 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
608 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
609 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
610 DIPLOPIA 14 0.0005
611 BACTERIAL INFECTION 10 0.0005
612 PULMONARY CONGESTION 7 0.0005
613 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
614 IMPAIRED DRIVING ABILITY 6 0.0005
615 DERMATITIS CONTACT 6 0.0005
616 COMA 25 0.0005
617 SLEEP APNOEA SYNDROME 10 0.0005
618 MUSCULOSKELETAL DISCOMFORT 9 0.0005
619 SKIN DISCOLOURATION 24 0.0005
620 THYROID DISORDER 8 0.0005
621 BACK PAIN 120 0.0005
622 VASCULITIS 6 0.0005
623 NERVOUS SYSTEM DISORDER 16 0.0005
624 PHARYNGEAL SWELLING 5 0.0005
625 MULTIPLE ALLERGIES 4 0.0005
626 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
627 AFFECTIVE DISORDER 4 0.0005
628 HOSPICE CARE 5 0.0005
629 ATAXIA 6 0.0005
630 ANAPHYLACTIC SHOCK 13 0.0005
631 LETHARGY 29 0.0005
632 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
633 HYPERLIPIDAEMIA 6 0.0005
634 RASH ERYTHEMATOUS 24 0.0005
635 NECK PAIN 28 0.0005
636 MASS 7 0.0005
637 TOOTHACHE 9 0.0005
638 SKIN REACTION 7 0.0005
639 MENTAL IMPAIRMENT 12 0.0005
640 RESTLESS LEGS SYNDROME 9 0.0005
641 MUSCLE DISORDER 4 0.0005
642 HYPERSOMNIA 14 0.0005
643 CARDIOGENIC SHOCK 7 0.0005
644 ESCHERICHIA INFECTION 4 0.0005
645 GENERALISED TONIC-CLONIC SEIZURE 8 0.0005
646 SEPTIC SHOCK 21 0.0005
647 PNEUMONIA ASPIRATION 12 0.0005
648 HYPERSENSITIVITY 88 0.0005
649 JOINT DISLOCATION 5 0.0005
650 CARDIOVASCULAR DISORDER 12 0.0005
651 DEHYDRATION 63 0.0005
652 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
653 HYPOTHYROIDISM 15 0.0005
654 SCAR 8 0.0005
655 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
656 IRRITABLE BOWEL SYNDROME 10 0.0005
657 HAEMOPTYSIS 13 0.0005
658 SKIN CANCER 10 0.0005
659 PNEUMONIA 150 0.0005
660 ASTHENIA 174 0.0005
661 SKIN SWELLING 4 0.0005
662 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
663 PULMONARY THROMBOSIS 5 0.0005
664 CONTUSION 44 0.0005
665 PRODUCT STORAGE ERROR 40 0.0005
666 IMMUNE SYSTEM DISORDER 6 0.0005
667 PHARYNGEAL OEDEMA 7 0.0005
668 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
669 GRIP STRENGTH DECREASED 4 0.0005
670 HAEMATOCRIT DECREASED 9 0.0005
671 CORONAVIRUS INFECTION 3 0.0005
672 ADVERSE REACTION 6 0.0005
673 NERVE INJURY 5 0.0004
674 ABORTION SPONTANEOUS 18 0.0004
675 CHRONIC KIDNEY DISEASE 34 0.0004
676 FEEDING DISORDER 9 0.0004
677 PLEURAL EFFUSION 27 0.0004
678 OPTIC NEURITIS 4 0.0004
679 MYOCARDITIS 5 0.0004
680 INFECTION 63 0.0004
681 HERPES ZOSTER 25 0.0004
682 SHOCK 10 0.0004
683 GASTRIC HAEMORRHAGE 5 0.0004
684 MUSCLE TWITCHING 10 0.0004
685 GRAND MAL CONVULSION 4 0.0004
686 BLOOD POTASSIUM DECREASED 13 0.0004
687 ABDOMINAL DISTENSION 45 0.0004
688 WOUND 12 0.0004
689 BLINDNESS UNILATERAL 6 0.0004
690 BLOOD SODIUM DECREASED 8 0.0004
691 RETCHING 9 0.0004
692 SPUTUM DISCOLOURED 4 0.0004
693 BLOOD URINE PRESENT 8 0.0004
694 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
695 INCORRECT DOSE ADMINISTERED 96 0.0004
696 CHOLECYSTITIS 5 0.0004
697 MYOCLONUS 5 0.0004
698 GASTRITIS 11 0.0004
699 PRURITUS GENERALISED 9 0.0004
700 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
701 ATELECTASIS 4 0.0004
702 ARTHROPATHY 23 0.0004
703 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
704 VITAMIN D DEFICIENCY 4 0.0004
705 HAEMORRHOIDS 8 0.0004
706 CHOKING 8 0.0004
707 PHARYNGITIS 5 0.0004
708 IMMUNODEFICIENCY 6 0.0004
709 DEPRESSION 91 0.0004
710 PREGNANCY 8 0.0004
711 RESPIRATORY DISTRESS 11 0.0004
712 LACRIMATION INCREASED 12 0.0004
713 PROCEDURAL PAIN 11 0.0004
714 SUBARACHNOID HAEMORRHAGE 4 0.0004
715 SLUGGISHNESS 4 0.0004
716 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
717 THIRST 7 0.0004
718 BOWEL MOVEMENT IRREGULARITY 3 0.0004
719 MENTAL DISORDER 17 0.0004
720 ANXIETY 111 0.0004
721 LYMPHOMA 6 0.0004
722 INFLAMMATION 20 0.0004
723 DIARRHOEA 250 0.0004
724 APNOEA 3 0.0004
725 MEMORY IMPAIRMENT 52 0.0004
726 INCONTINENCE 4 0.0004
727 MUSCULAR WEAKNESS 43 0.0004
728 MOBILITY DECREASED 27 0.0004
729 BLOOD DISORDER 3 0.0004
730 RASH MACULAR 13 0.0004
731 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
732 SKIN LESION 10 0.0004
733 TOOTH FRACTURE 4 0.0004
734 BALANCE DISORDER 31 0.0004
735 DEMENTIA 10 0.0004
736 OCULAR DISCOMFORT 4 0.0004
737 FEMUR FRACTURE 11 0.0004
738 CHROMATURIA 8 0.0004
739 STATUS EPILEPTICUS 4 0.0004
740 SINUS TACHYCARDIA 5 0.0004
741 CHOLECYSTECTOMY 4 0.0003
742 SPINAL FRACTURE 7 0.0003
743 SOMNOLENCE 70 0.0003
744 CONFUSIONAL STATE 56 0.0003
745 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
746 HAEMATOCHEZIA 19 0.0003
747 POST PROCEDURAL HAEMORRHAGE 4 0.0003
748 MUSCULOSKELETAL PAIN 18 0.0003
749 NEUTROPHIL COUNT DECREASED 14 0.0003
750 COLITIS 13 0.0003
751 DYSSTASIA 10 0.0003
752 HYPERKALAEMIA 12 0.0003
753 MYALGIA 58 0.0003
754 HYPOXIA 12 0.0003
755 ARTHRALGIA 141 0.0003
756 DISEASE RECURRENCE 16 0.0003
757 PULMONARY MASS 5 0.0003
758 CHOLELITHIASIS 11 0.0003
759 MUSCLE SPASMS 61 0.0003
760 HEPATITIS C 4 0.0003
761 RENAL FAILURE ACUTE 14 0.0003
762 PRODUCT USE ISSUE 62 0.0003
763 C-REACTIVE PROTEIN INCREASED 12 0.0003
764 NOCTURIA 4 0.0003
765 IMPAIRED WORK ABILITY 7 0.0003
766 EYE PRURITUS 11 0.0003
767 BRAIN NEOPLASM 3 0.0003
768 RESPIRATORY ARREST 9 0.0003
769 RASH 141 0.0003
770 HEPATIC STEATOSIS 6 0.0003
771 LUNG INFECTION 5 0.0003
772 TOOTH EXTRACTION 4 0.0003
773 GASTRIC DISORDER 11 0.0003
774 BASAL CELL CARCINOMA 5 0.0003
775 VISION BLURRED 44 0.0003
776 SECRETION DISCHARGE 4 0.0003
777 HEPATIC CIRRHOSIS 6 0.0003
778 ARTERIOSCLEROSIS 3 0.0003
779 MELAENA 7 0.0003
780 DERMATITIS ALLERGIC 4 0.0003
781 MUSCLE ATROPHY 4 0.0003
782 MUSCULOSKELETAL DISORDER 6 0.0003
783 PRODUCT USE IN UNAPPROVED INDICATION 78 0.0003
784 ULCER 5 0.0003
785 RASH PAPULAR 7 0.0003
786 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
787 AFFECT LABILITY 3 0.0003
788 PRESCRIBED OVERDOSE 6 0.0003
789 HAEMATOMA 8 0.0003
790 IMPAIRED HEALING 10 0.0003
791 ORAL CANDIDIASIS 4 0.0003
792 BLADDER DISORDER 3 0.0003
793 CYTOMEGALOVIRUS INFECTION 5 0.0003
794 BREAST CANCER FEMALE 8 0.0003
795 PERICARDITIS 5 0.0003
796 HAEMATURIA 10 0.0003
797 DRUG DOSE OMISSION 48 0.0003
798 RESPIRATORY FAILURE 21 0.0003
799 GAIT DISTURBANCE 55 0.0003
800 APHONIA 4 0.0003
801 LUNG DISORDER 14 0.0003
802 BLISTER 16 0.0003
803 NEOPLASM MALIGNANT 19 0.0003
804 CONSTIPATION 62 0.0003
805 PULMONARY EMBOLISM 27 0.0003
806 LYMPHADENOPATHY 10 0.0003
807 BREAST PAIN 3 0.0003
808 THERAPEUTIC RESPONSE DECREASED 17 0.0003
809 PARALYSIS 4 0.0003
810 BREAST CANCER METASTATIC 3 0.0003
811 IMPAIRED QUALITY OF LIFE 4 0.0003
812 FAECES DISCOLOURED 6 0.0003
813 HYPERTHYROIDISM 4 0.0003
814 BIPOLAR DISORDER 3 0.0003
815 BONE DISORDER 5 0.0003
816 PANIC ATTACK 10 0.0003
817 OSTEONECROSIS 9 0.0003
818 ASPIRATION 3 0.0003
819 UNRESPONSIVE TO STIMULI 7 0.0003
820 LABORATORY TEST ABNORMAL 8 0.0003
821 RASH GENERALISED 7 0.0003
822 SKIN HAEMORRHAGE 4 0.0003
823 SKIN DISORDER 9 0.0003
824 COLON CANCER 4 0.0003
825 THINKING ABNORMAL 5 0.0003
826 HAEMORRHAGE INTRACRANIAL 4 0.0003
827 JOINT STIFFNESS 7 0.0003
828 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
829 IRRITABILITY 16 0.0003
830 HEPATIC FAILURE 8 0.0003
831 DYSPEPSIA 26 0.0003
832 GASTRIC ULCER 5 0.0003
833 FEELING JITTERY 5 0.0003
834 EPILEPSY 8 0.0003
835 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
836 ACUTE RESPIRATORY FAILURE 5 0.0003
837 AGITATION 19 0.0003
838 RASH PRURITIC 14 0.0003
839 ORAL HERPES 5 0.0003
840 BONE PAIN 15 0.0003
841 COVID-19 PNEUMONIA 3 0.0003
842 HAEMOGLOBIN DECREASED 26 0.0003
843 OCULAR HYPERAEMIA 12 0.0003
844 DYSPHAGIA 24 0.0003
845 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
846 ABNORMAL BEHAVIOUR 10 0.0003
847 MENTAL STATUS CHANGES 7 0.0003
848 VISUAL IMPAIRMENT 31 0.0002
849 BLOOD GLUCOSE DECREASED 12 0.0002
850 HAEMORRHAGE 26 0.0002
851 PRODUCT ADMINISTRATION ERROR 5 0.0002
852 MUSCLE TIGHTNESS 4 0.0002
853 DYSKINESIA 10 0.0002
854 DEPRESSED MOOD 13 0.0002
855 ENCEPHALOPATHY 6 0.0002
856 ABASIA 6 0.0002
857 ANAEMIA 46 0.0002
858 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
859 EPISTAXIS 18 0.0002
860 POLLAKIURIA 10 0.0002
861 URINARY RETENTION 8 0.0002
862 COGNITIVE DISORDER 11 0.0002
863 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
864 CATARACT 14 0.0002
865 POOR QUALITY SLEEP 5 0.0002
866 JOINT SWELLING 28 0.0002
867 ASTHMA 26 0.0002
868 ORTHOSTATIC HYPOTENSION 4 0.0002
869 LOCAL SWELLING 4 0.0002
870 MUSCULOSKELETAL STIFFNESS 20 0.0002
871 EMOTIONAL DISORDER 7 0.0002
872 PANCREATITIS 12 0.0002
873 SLEEP DISORDER 16 0.0002
874 PANCREATITIS ACUTE 5 0.0002
875 EXTRA DOSE ADMINISTERED 9 0.0002
876 AGGRESSION 11 0.0002
877 DECREASED APPETITE 51 0.0002
878 CONJUNCTIVITIS 4 0.0002
879 DEEP VEIN THROMBOSIS 14 0.0002
880 INTESTINAL OBSTRUCTION 8 0.0002
881 FLATULENCE 12 0.0002
882 HYPOCALCAEMIA 4 0.0002
883 FRACTURE 4 0.0002
884 NERVOUSNESS 11 0.0002
885 RECTAL HAEMORRHAGE 9 0.0002
886 GLAUCOMA 4 0.0002
887 VAGINAL HAEMORRHAGE 9 0.0002
888 ANGER 7 0.0002
889 APATHY 3 0.0002
890 HEPATIC ENZYME INCREASED 14 0.0002
891 DEATH 176 0.0002
892 BREAST CANCER 19 0.0002
893 ANGIOEDEMA 9 0.0002
894 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
895 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
896 HAEMATEMESIS 5 0.0002
897 DIABETES MELLITUS 15 0.0002
898 BLINDNESS 8 0.0002
899 ERECTILE DYSFUNCTION 5 0.0002
900 TOOTH LOSS 4 0.0002
901 EYE SWELLING 7 0.0002
902 ABSCESS 3 0.0002
903 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
904 INTERSTITIAL LUNG DISEASE 9 0.0002
905 HOT FLUSH 14 0.0002
906 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
907 THERAPY INTERRUPTED 13 0.0002
908 VISUAL ACUITY REDUCED 6 0.0002
909 RASH MACULO-PAPULAR 4 0.0002
910 GAIT INABILITY 6 0.0002
911 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
912 ARTHRITIS 14 0.0002
913 SUICIDAL IDEATION 16 0.0002
914 HYPOKALAEMIA 8 0.0002
915 DELIRIUM 6 0.0002
916 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
917 ASCITES 5 0.0002
918 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
919 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
920 PSYCHOTIC DISORDER 5 0.0002
921 URINARY INCONTINENCE 5 0.0002
922 OFF LABEL USE 147 0.0002
923 DISTURBANCE IN ATTENTION 9 0.0002
924 ADVERSE EVENT 15 0.0002
925 MEDICATION ERROR 9 0.0002
926 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
927 HYPONATRAEMIA 9 0.0002
928 EYE PAIN 9 0.0002
929 HYPOPHAGIA 4 0.0002
930 COMPLETED SUICIDE 13 0.0002
931 NO ADVERSE EVENT 28 0.0002
932 DYSPHONIA 9 0.0002
933 EYE DISORDER 5 0.0002
934 BLOOD CHOLESTEROL INCREASED 7 0.0002
935 BLOOD BILIRUBIN INCREASED 4 0.0001
936 INSOMNIA 39 0.0001
937 OSTEOPOROSIS 6 0.0001
938 HYPOGLYCAEMIA 7 0.0001
939 DEVICE MALFUNCTION 10 0.0001
940 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
941 PLATELET COUNT DECREASED 15 0.0001
942 SKIN BURNING SENSATION 10 0.0001
943 EYE IRRITATION 8 0.0001
944 MYELOSUPPRESSION 5 0.0001
945 CRYING 5 0.0001
946 HYPERGLYCAEMIA 5 0.0001
947 DRY MOUTH 11 0.0001
948 DYSGEUSIA 10 0.0001
949 HEPATIC FUNCTION ABNORMAL 5 0.0001
950 PREMATURE BABY 4 0.0001
951 INJURY 9 0.0001
952 MULTIPLE SCLEROSIS 6 0.0001
953 MOVEMENT DISORDER 4 0.0001
954 PROSTATE CANCER 10 0.0001
955 DEVICE ISSUE 11 0.0001
956 FUNGAL INFECTION 4 0.0001
957 TYPE 2 DIABETES MELLITUS 4 0.0001
958 BLOOD GLUCOSE INCREASED 22 0.0001
959 SUICIDE ATTEMPT 7 0.0001
960 ADVERSE DRUG REACTION 10 0.0001
961 INTENTIONAL PRODUCT MISUSE 9 0.0001
962 PLASMA CELL MYELOMA 4 0.0001
963 DRY EYE 5 0.0001
964 STOMATITIS 6 0.0001
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
966 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
967 ECZEMA 5 0.0001
968 OSTEOARTHRITIS 4 0.0001
969 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
970 DRUG INTOLERANCE 9 0.0001
971 ACUTE KIDNEY INJURY 14 0.0001
972 THROMBOCYTOPENIA 10 0.0001
973 UNDERDOSE 6 0.0001
974 ALOPECIA 16 0.0001
975 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
976 LEUKOPENIA 4 0.0001
977 HALLUCINATION 6 0.0001
978 DRY SKIN 10 0.0001
979 OVERDOSE 15 0.0001
980 DRUG INTERACTION 11 0.0001
981 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
982 COLORECTAL CANCER 3 0.0001
983 INJECTION SITE REACTION 4 0.0001
984 ACNE 4 0.0001
985 INJECTION SITE SWELLING 4 0.0001
986 BLADDER CANCER 3 0.0001
987 DRUG INEFFECTIVE 63 0.0000
988 PRODUCT QUALITY ISSUE 6 0.0000
989 TOXICITY TO VARIOUS AGENTS 5 0.0000
990 NEUTROPENIA 4 0.0000
991 INJECTION SITE PAIN 9 0.0000